Search companies

Live

OSTEOPORE LIMITED (ASX: OSX)

Health care · News and insights

Price unavailable

Latest OSX announcements

Osteopore To Take Singapore Orthopaedic Sales In-House From 2027

2026-11-02 · Health care

OSX: $0.004 +0.00% · MC: $2M

Osteopore’s subsidiary and DKSH Singapore have agreed to end their exclusive sales and marketing arrangement for Osteopore’s orthopaedic products at the end of 2026, ahead of its scheduled expiry, with Osteopore International set to take over from 2027. The company says direct management is intended to strengthen customer engagement as it expands 3D-printing services and prepares to introduce an injectable bone filler; DKSH’s arrangement began in 2024.

Updated 2026-11-02 09:27
Share
SourcesOSX focuses on Ortho line in Singapore via direct selling
Comments

Osteopore Posts Record Quarterly Revenue, Up 27% From Previous Quarter

2026-10-30 · Health care

OSX: $0.004 +0.00% · MC: $2M

Osteopore reported record quarterly revenue of approximately A$859,000, up 27% quarter on quarter and 6% year on year. The update also highlights new market access for orthopaedic products in Thailand and Saudi Arabia, alongside a first custom implant delivered and implanted in Hainan.

Updated 2026-10-30 18:10
Share
SourcesActivities Report September 2026 and Appendix 4C
Comments